ASCAT 2023 | Gene therapy approaches to treating SCD and thalassemia
Miguel Abboud
• 27 Oct 2023
In this video, Miguel Abboud, MD, American University of Beirut Medical Center, Beirut, Lebanon, briefly comments on some gene therapy approaches which are being considered for the treatment of sickle cell disease (SCD) and thalassemia, due to their ability to ameliorate symptoms of the disease in patients. This interview was recorded at the 18th Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT) 2023, held in London, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
